Objective: The diagnostic accuracy of MSCT and MRI for evaluation of hepatic focal lesions.
Introduction
ADVANCES in imaging techniques, notably computed tomography, magnetic resonance imaging and ultrasound have increased our ability to detect and characterize focal liver lesions, resulting in improvements in diagnostic capability and im- proved monitoring of liver focal lesions and metastases [1] .
MRI is frequently used as a problem solving technique for the evaluation of focal hepatic lesions that are deemed indeterminate with other imaging modalities particularly in patients with history of malignancy or with underlying liver diseases "cirrhosis" [2] .
MDCT performed statistically better than MRI in lesion detection [3] .
In hepatic hemangioma, MRI sensitivity is 96%, However, combined MDCT and MRI, the sensitivity could be 100%.
Both hepatic adenoma and hypervascular metastases demonstrates intense enhancement on arterial phase [2] .
In the preoperative evaluation of HCC, it is important to diagnose accurately the number and location of HCCs to choose the most appropriate surgical procedure and improve therapeutic outcome [4] .
So, this study was performed to explore the effectiveness, and hence the clinical utility, of CT and MR characterization of focal hepatic lesions.
Patients and Methods
The subjects in this study comprised 61 patients with 95 Hepatic focal lesions. They underwent both MR imaging and 64 MSCT triphasic imaging. The patients included 37 men and 24 women who ranged in age from 19 to 74 years (mean age, 46.5 years). Proof of definite diagnosis was obtained by biopsy or surgical resection of 59 lesions in 31 patients. The other lesions, which were not surgically treated, were confirmed on the basis of a combination of clinical, laboratory and radiologic criteria, including a response to treatment [6] .
Exclusion criteria:
Focal lesions exposed to therapeutic intervention as surgery, RF ablation, aspiration or chemoembolization.
Sample type: Comprehensive sample.
Study design: Analytic, comparative study.
Methods:
CT exams were performed using GE, light speed VCT 64 slices. 120mL of a nonionic iodinated contrast agent (Omnipaque 350mg I/ml, Iohexol, GE, Ireland) at a rate of 3-4mL/s with a bolus-triggered technique [4] .
MR imaging was performed with a superconducting imager at 1.5 T (GE Signa HDxt). MR contrast used was Omniscan (Gadodiamide, 0.5 mmol/ml, GE, Ireland), 0.2mmol/kg, was handinjected IV and followed by a saline flush.
Image analysis:
Two blinded observers with at least 5 years experience in interpretation of CT and MRI. Each observer independently recorded the presence and segmental location of lesions using a 4-point confidence scale based on previous studies [4] : 1, no focal lesion; 2, probably no focal lesion; 3, probable focal lesion; 4, definite focal lesion.
Lesion detection and characterization:
The number of hepatic lesions per sequence on a segment-by-segment basis. Eight anatomic hepatic segments were defined on the basis of the numbering system of Couinaud. For CT density and MRI sequences, it is recorded the segmental location and the size of each lesion and then assigned as present or absent [17] (Table 1) .
Hypoenhancing benign lesions:
Hepatic simple cysts, on CT, low attenuation (0-10HU) and do not enhance on contrast study. Markedly hypointense on T1 WI, markedly hyperintense on T2, no internal enhancement, very thin wall, well defined margins [7] . Regenerating nodules; it is seen as low signal intensity on both T1 and T2 WI with minimal enhancement after contrast ( Fig. 1 ).
Dysplastic nodules:
Generally hypointense or more commonly hyperintense on T1 WI, and iso or hypointense on T2 WI without prominent arterial phase enhancement (as the main blood supply is from the portal venous system). Dysplastic nodules are not hyperintense on T2 WI [8] .
Malignant hypoenhancing lesions: Hypovascular metastases ( Fig. 2) : Colon, lung, prostate, gastric and transitional cell carcinoma, usually show low signals on T1 and iso to hyperintense on T2 with delayed enhancement. Occasionally show early ring enhancement ( Fig. 3 ).
Focal fat: displays low signals on CT, shows signal loss on opposed phase images and no enhancement [9] .
Echinococcus infestations: Central necrosis and micro-calcifications are common. CT display heterogeneous hypodense areas without enhancement. T2 display high signals ( Fig. 4 ) of peripheral cystic extensions, other lesion is hypointense on T1 and T2 WI [10] .
Benign arterial phase enhancing lesions: Adenoma: Hypodense on CT, but may be hyperdense or heterogeneous due to hemorrhage. Adenomas range from mildly hypo to hyperintense on T1 WI. The high signal due to fat or blood products. On T2, non specific heterogeneous slightly hyperintense lesions. Immediate enhancement in arterieal phase but rapidly fades to nearly isointense on delayed phase.
Focal nodular hyperplasia ( Fig. 5 ): Appears as hypodense on CT with central non enhancing scar. On MRI, iso on T1, iso to hyperintense on T2. Central scar is hyperintense on T2. It displays arterial enhancement and scar may enhance on delayed scans [11] .
Malignant arterial phase enhancing lesions:
HCC, Commonly hypodense on CT ( Fig. 6 ). On T1, hypointense, although high signals lesions or areas of mixed signals may be seen. High signals within HCC reflect fat, copper, protein, blood. On T2, HCC generally hyperintense, although isointense lesions may be seen. Most HCC show intense arterial enhancement. Large HCC may have mosaic pattern [12] .
Hypervascular metastases: Islet cell tumors, breast cancer, melanoma, thyroid cancer, carcinoid. They have high signals on T2, and arterial enhancement.
Hemangiomas:
On CT, it appears as nodular hypodense homogenous lesions, peripheral, centripetal enhancement in arterial and portal phase and homogenous enhancement in delayed phase. On MRI ( Fig. 7) , it display hypointense lesion on T 1 and hyperintense on T2 and enhanced like CT [13] .
Statistical analysis:
The sensitivity for each observer and technique was calculated, and the statistical analysis for differences of the sensitivities was performed with the McNemar test [14] . Kappa statistics were used to assess interobserver agreement in the detection of focal lesions with each technique [15] .
Results
After through clinical examination and history taking, the patient underwent these imaging examinations ( Table 1 ). The hepatic focal lesions are categorized according to cystic and solid lesions, size of the lesion ( <2cm and >2cm) [16] .
The 95 focal lesions ranged in size from 4 to 100mm (mean, 52mm), 62 were less than or equal to 20mm in diameter (range, 4-20mm; mean, 12 mm), and 33 were greater than 20mm (range, 21-100mm; mean, 60.5mm).
Detection of focal hepatic lesions by CT and MRI for hemangioma was 80% in CT and 92% in MRI. In metastases, the values much less (63.3% and 84.2% respectively). However, detection was perfect (100%) in hydatid cyst, FNH and adenoma in both CT and MRI ( Table 2 ). In cases of HCC, MRI could detect 90.3% of cases, whether CT could detect 58.6% only.
The detection sensitivity for tumors of two size categories (<2cm or 2cm) and the positive predictive values for each of the two observers are shown in Tables (3&4) . Using MR imaging alone, observers 1,2 detected 42.6% and 53.3% of focal lesions less than or equal to 2cm and detect 97%, 96.8% of focal lesions more than 2cm respectively. Using MDCT, they detect 47.4% and 49.2% of lesions less than or equal to 2cm, and 84.4%, 90.6% of lesions more than 2cm.
The problem as shown in Table ( (Table 5 ).
Enhancement pattern in arterial phase was analyzed ( Table 6 ). In HCC, the most specific pattern was abnormal internal vessels (96%). In cases of hemangiomas, peripheral puddles was highly specific (98.4%). In metastases, enhancement pattern was not highly specific in both complete and incomplete ring (86.8%, for each).
The kappa values for the three observers, calculated on the basis of each observer's confidence level for the alternative free-response ROC analysis, were 0.77 for MR imaging and 0.79 for CT and showed substantial agreement with regard to the presence of lesions.
In all the patients, MDCT provided the optimum arterial and venous images without any significant motion or artifacts.
A total of 31 HCC were ascertained pathologically. In CT, the typical signs of HCC were hyperattenuation in the hepatic arterial phase and hypoattenuation in the portal venous phase and delayed phase. MSCT had a sensitivity of 62% and its false-positive rate was 35.5% (11/31).
Carcinoma thrombosis was detected in the left branch of the portal vein in 1 patient and in the right branch in 2 patients. The transverse diameter of the involved portal vein ranged from 12cm to 25mm. Three patients were accompanied with some degree of cavernous transformation of the portal vein.
In two patients MRI & MSCT images revealed tumor involvement of the biliary duct, which was dilated. In 2 patients, peritoneal implants were confirmed surgically, but were not demonstrated by MRI & MSCT before operation. 
Discussion
In a meta-analysis of hepatic metastases from cancers of the gastrointestinal tract, Kinkel [18] , reported a mean sensitivity of 72% for CT, based on 25 publications that included 1,747 patients. In another study with surgically proven liver lesions, a sensitivity of 69% to 71% and a specificity of 86% to 91% was shown using dual-phase helical CT 15.
In a study of Khalid, et al. [2] , 55% diagnosis of metastatic focal hepatic lesions by MRI as compared with 17% for CT. In our study, the sensitivity and specificity of CT were 60%, 84% and for MRI were 76.2, 87.8% in metastases. The numbers is different along these studies because of undetermined lesion size mentioned in the other studies; however, there is a difference in resolution of using MSCT in this study.
More recent comparisons of noninvasive imaging modalities, primarily MDCT and MRI, have shown equally accurate if not better lesion detection of MDCT.
Advancements in both MRI hardware and image acquisition techniques have had a major impact in abdominal imaging, particularly hepatic imaging [19, 20] . However, in our study, in hemangiomas, the sensitivity and specificity of CT were 76.9%, 88.4% and for MRI were 85.2, 91.2%, whereas, in HCC, the sensitivity and specificity of CT were 62%, 83.3% and for MRI were 90.3, 87.5% in metastases, sensitivity and specificity of CT were 60%, 84% and for MRI were 76.2, 87.8%. These results are somewhat like in previous studies, as mentioned [4, 21] .
In study using 64 MDCT and MRI [4] , about detection sensitivity of MRI and MSCT, the differences between the two techniques were insignificant. Also, the numbers of false-positive MRI findings were the same as or relatively low compared with those for MSCT. Eighty percent of the false-positive MRI results and 67% of the false-positive CT results were primarily attributed to arterioportal shunt. In our study, MRI was almost the same as CT to detect focal hepatic lesions, whether small, lesions <2, sensitivity of MRI was 48% and CT was 48.3%, and also in lesions >2cm, sensitivity of MRI was 96.9% and CT was 96.9%, however, the specificity of MRI is significantly higher than CT. Also, Cirrhosis-related benign nodules may exhibit predominant hypoattenuation on contrast-enhanced portal or delayed phase CT images [22] and might not be differentiated from hypovascular HCC. In the same study of Seong, et al., 2009, 33% of false-positive findings on MDCT were attributed to prominent cirrhosisrelated nodules, in our study, 11 cases of false positive HCC lesions, 5 of them related to cirrhosisrelated nodules (45.5%). In that study, the numbers of false-negative MRI findings were relatively low compared with the false-negative MDCT findings. In our study, 11 lesions of false negative in CT whereas, only 3 lesions in MRI.
A study by Matilde, at al. [23] , 92% of the 100 lesions demonstrated arterial enhancement. Patterns associated with positive predictive values of 82% or greater and specificity of 80% or greater included abnormal internal vessels or variegated (hepatocellular carcinoma), peripheral puddles (hemangioma) (Fig. 2) , and complete ring (metastasis). In our study, arterial enhancement is seen in 100% of HCC, hemangioma and metastases. Our study is matched with this study, as abnormal internal vessels was specific for HCC (96%), peripheral puddles (hemangioma, 98.4% specific), complete and incomplete ring (metastasis, 86.8%).
The abnormal internal vessels or variegated pattern indicated HCC with a PPV of 75% and a specificity of 96%. It displays either abnormal internal vessels or randomly distributed components of both hyperattenuation and hypoattenuation. The definition for abnormal internal vessels required vessels to be irregular in contour or to branch erratically, findings that reflected neovascularity associated with malignancy in angiographic studies.
The peripheral puddles pattern was associated with hemangiomas, the PPV and specificity of this pattern for hemangioma were 92.3% and 98.4%, respectively. The appearance of discrete welldefined peripheral globules isoattenuating with vascular structures has been well established as characteristic of hemangiomas [24] .
Lesions with circumferential ring enhancement usually malignant. When all lesions exhibiting this enhancement pattern were considered, malignancy was predicted, as specificity for metastases was 86.8%.
An important observation is that overlap can occur between the appearances of benign and malignant lesions. For example, as found in this study and others [23] , the homogeneous pattern can be exhibited by lesions such as HCC, hemangiomas, and FNH. Additionally, we found overlap between the peripheral puddles pattern typical of hemangiomas and the enhancement exhibited by metastasis. Correlation with portal venous phase images may help differentiate lesions that exhibit similar arterial phase enhancement patterns. Few hemangiomas and hypervascular metastases were included in our study, and further work will be necessary to more fully examine their enhancement patterns.
In the study, 7 cases of HCC (22.6%), had ring and peripheral enhancement. The appearance of HCC depends largely on tumor size and histologic grade. Small HCC have a proportionately greater arterial hepatic blood supply and as a result they may be visible on arterial phase with washout on portal phase. In larger lesions, the portal vein may also contribute significantly to the blood supply of HCC enabling its visualization on porto-venous phase as well, however, because large tumor may contain areas of hemorrhage or necrosis, they may be seen as either hyper or hypodense during arterial phase. Irregular mosaic or peripheral enhancement is usually seen in larger HCC depending on the internal architecture [25] . In moderately differentiated HCC, peak of enhancement is seen on arterial phase with rapid washout in portal and delayed phases, however, gradual increasing enhancement overtime is found in poorly differentiated scirrhous HCC, also HCC pseudo capsule congaing abundant granulation tissue usually enhanced on venous and delayed phases [26] .
FNH, in as many as 20% of patients, a scar may not be visible [27] , but in our study, all cases presented with scar. One case of FNH displays drop out signal on out of phase (fatty contents), except the central scar, the authors considered it as an exaggerated expression of this patient's native hepatic disease characterized by fatty liver [28, 29] .
Cases of false negative equal to 2cm or smaller in diameter were not detected with MDCT or MRI by any observer, exhibited poor conspicuity and subtle hypervascularity on arterial phase images; in two of the lesions no washout pattern was seen on delayed CT scans. The observers considered these HCCs arterioportal shunts and misidentified them at CT image interpretation.
